Posts Tagged ‘ssri’

Before you take that antidepressant, visit website feauturing 3,500 crimes/suicides related to antidepressant use

Monday, January 4th, 2010

Martha Rosenberg
OpEdNews.com
January 3, 2010

With our national love of drugs, sex, celebrities and violence you’d think SSRIstories.com would be more popular.

The 12-year-old web site lists 3,500 crime related news reports linked to the use of SSRI antidepressants with celebrities like Wynona Ryder, Heath Ledger, Brittany Murphy, Anna Nicole Smith, Heather Locklear, Glen Campbell, Carrie Fisher, Sharon Osbourne, Phil Hartman, Princess Di’s driver, Patrick Swayze’s Sister, O.J. Simpson and the Crown Prince of Nepal generously sprinkled in.

You can search and sort stories by drug–Lexapro, Celexa, Luvox, Prozac, Zoloft and Paxil and the related Effexor and Cymbalta–date, location, type of violence and the articles about school shootings, famous cases and legal cases won on SSRI defenses are color coded.

You don’t even have to read the whole article.

SSRIstories founder and manager Betty Henderson pulls out and boldfaces the story’s drug-related citation like Lynyrd Skynyrd harmonicist Mike Caruso’s remark that, “the doctor put me on Cymbalta. That turned me manic,” and Oklahoma murder suspect Ronson Bush’s remark, “I killed my friend when I took these. I’m not going to take them,” when offered SSRIs at the Grady County Jail.

Read entire article: http://www.opednews.com/articles/Before-You-Take-That-Antid-by-Martha-Rosenberg-100103-313.html

« Return to news items


  • Share/Bookmark

Glaxo Said to Have Paid $1 Billion in Paxil Suits Including About $390 Million for Suicides/Attempted Suicides Linked to Drug

Monday, December 14th, 2009

Jef Feeley and Margaret Cronin Fisk
Bloomberg.com
December 14, 2009

GlaxoSmithKline Plc has paid almost $1 billion to resolve lawsuits over Paxil since it introduced the antidepressant in 1993, including about $390 million for suicides or attempted suicides said to be linked to the drug, according to court records and people familiar with the cases.

As part of the total, Glaxo, the U.K.’s largest drugmaker, so far has paid $200 million to settle Paxil addiction and birth-defect cases and $400 million to end antitrust, fraud and design claims, according to the people and court records.

The $1 billion “would be worse than many people are expecting,” said Navid Malik, an analyst at Matrix Corporate Capital in London. “I don’t think this is within the boundaries of current assumptions for analysts.”

The London-based company hasn’t disclosed the settlement total in company filings. It has made public some accords. Glaxo’s provision for legal and other non-tax disputes as of the end of 2008 was 1.9 billion pounds ($3.09 billion), according to its latest annual report. This included all legal matters, not just Paxil. The company said 112 million pounds of this sum would be “reimbursed by third-party issuers.”

Read entire article: http://www.bloomberg.com/apps/news?pid=20601103&sid=aWNKB4YPWjIY

« Return to news items


  • Share/Bookmark

US Kids Represent Psychiatric Drug Goldmine

Monday, December 14th, 2009

Truthout
Evelyn Pringle
December 12, 2009

Prescriptions for psychiatric drugs increased 50 percent with children in the US, and 73 percent among adults, from 1996 to 2006, according to a study in the May/June 2009 issue of the journal Health Affairs. Another study in the same issue of Health Affairs found spending for mental health care grew more than 30 percent over the same ten-year period, with almost all of the increase due to psychiatric drug costs.

On April 22, 2009, the US Agency for Healthcare Research and Quality reported that in 2006 more money was spent on treating mental disorders in children aged 0 to 17 than for any other medical condition, with a total of $8.9 billion. By comparison, the cost of treating trauma-related disorders, including fractures, sprains, burns, and other physical injuries, was only $6.1 billion.

In 2008, psychiatric drug makers had overall sales in the US of $14.6 billion from antipsychotics, $9.6 billion off antidepressants, $11.3 billion from antiseizure drugs and $4.8 billion in sales of ADHD drugs, for a grand total of $40.3 billion.

The path to child drugging in the US started with providing adolescents with stimulants for ADHD in the early 80s. That was followed by Prozac in the late 80s, and in the mid-90s drug companies started claiming that ADHD kids really had bipolar disorder, coinciding with the marketing of epilepsy drugs as “mood stablizers” and the arrival of the new atypical antipsychotics.

Read entire article: http://www.truthout.org/1213091

« Return to news items


  • Share/Bookmark

Exposing Psychiatry’s Billing Bible “Inside the DSM The Drug Barons’ Campaign to Make Us All Crazy”

Friday, August 21st, 2009

Eugenia Tsao
Counterpunch
August 20, 2009

Some years ago, a friend told me that he had been diagnosed with a major depressive disorder and that his psychiatrist had given him a prescription for Forest Laboratories’ popular SSRI antidepressant Celexa (chemical name, citalopram hydrobromide; $1.5 billion in sales in 2003). Knowing him to be a vociferous critic of the pharmaceutical companies, I asked whether he agreed that the origins of his unhappiness were biological in nature. He replied that he unequivocally did not. “But,” he confided, “now I might be able to get my grades back up.”

This guy was, at the time, a full-time undergraduate student who managed rent, groceries and tuition only by working two part-time jobs. He awoke before dawn each morning in order to transcribe interviews for a local graduate student, then embarked upon an hour-long commute to campus, attended classes until late afternoon, and then finally headed over to a nearby café to wash dishes until nine o’clock in the evening. By the time he arrived home each night, he was too exhausted to work on the sundry assignments, essays and lab reports that populated his course syllabi. As the school year dragged on, he had become increasingly disheartened about his slipping grades and mounting fatigue and decided, finally, that something had to be done. So he’d seen the psychiatrist and was now on Celexa.

Read entire article: http://www.counterpunch.org/tsao08202009.html

« Return to news items


  • Share/Bookmark

Doped Up and Duped – nearly impossible to find independent studies of psych drugs with no Pharma ties

Monday, August 10th, 2009

David Healy
guardian.co.uk
August 8, 2009

Adverse effects of widely-prescribed drugs are often overlooked because there is so little truly independent academic evidence

Since 2005, the SSRI paroxetine, first marketed by GlaxoSmithKline as Seroxat, has carried warnings of risk of birth defects. In the US litigation in which I have been asked to give evidence, the plaintives will argue that, even before they were launched, there was good laboratory evidence that the SSRIs might cause problems, and, following their initial marketing, evidence emerged over a decade ago from clinical use that the drugs actually do cause problems.

Yet these drugs have been actively promoted, de facto primarily to women of child-bearing years. How could this happen?

Part of the problem is that having gone to their GP with a nervous problem, many women become dependent on a prescribed SSRI and find it impossible to stop using it whether they wish to get pregnant or if they find they are pregnant while on treatment. But few, if any, of these women will have been informed of either the risk of birth defects or the risk of becoming addicted. Why not?

What we are seeing here is the astonishing marketing power of pharmaceutical companies, which can now effect huge changes in medical culture within months. In this case, a great part of the scientific literature (the primary marketing tool of companies) on the use of antidepressants in pregnancy and on dependence on antidepressants is ghostwritten – just as virtually all literature on giving antidepressants to children was, at one point, company-written.

Read entire article: http://www.guardian.co.uk/commentisfree/2009/aug/08/seroxat-pharmaceutical-birth-defect

« Return to news items


  • Share/Bookmark

Psychiatric Drugs, Violence and Suicide

Sunday, July 19th, 2009

police_tape_288x195K.L. Carlson
Former Pharmaceutical Rep.

People often go through times of depression due to job loss, relocation, loss of a loved one, divorce, and many other situations that cause us to feel insecure. Our bodies do have natural ways of dealing with these emotions especially if people use healthy means including adequate sleep, exercise, healthy eating and emotional support from friends and family.

SSRI/SNRI (Selective Serotonin Reuptake Inhibitors/Selective Norepinephrine Reuptake Inhibitors) are antidepressant drugs that interfere with the body-mind’s normal functioning. These drugs are literally mind-altering.  They can cause people to terminate loving, supportive relationships with family and friends, the very relationships that are extremely important to helping people recover from depression.  The drugs can cause hallucinations, paranoia, and mania.

There is a direct correlation with the increase of antidepressant drug use and the rise in extreme, senseless violent acts.  There are experts who have been trying to bring this to the attention of physicians, the FDA, and the public for more than a decade.  Depression is not the problem.  The drugs are the problem.

In 2001, GlaxoSmithKline was ordered to pay $6.4 million to the surviving family members after 60 year old Donald Schnell flew into a rage and killed his wife, daughter, and granddaughter only 48 hours after he began to take Paxil.

“I keep asking, when is somebody going to see this?  But we’ve been so brainwashed about drugs.  We think legal means safe,” Ann Blake Tracy, Ph.D. explains.  “Most people don’t know that LSD once was legal and prescribed as a wonder drug.  That PCP was considered to have a large margin of safety in humans. Most people don’t know that ecstasy was prescribed and sold for five years to treat depression.

The adverse effects of psychiatric drugs are regularly misdiagnosed as more signs of depression, anxiety or some other created-by-vote psychiatric disorder. Then patients are prescribed additional psychiatric drugs or the dosage is increased.  That was the case of California teenager Dominique Slater.  Only 14 years old she was on several antidepressants including Celexa and Wellbutrin. When her erratic behavior worsened her doctor prescribed double dose of Effexor.  Fifteen days later she killed herself.  She was barely a teenager yet she was prescribed multiple antidepressant drugs at high doses.  The year was 2003. Britain had already sent letters to all physicians sternly warning against the use of any of these drugs in anyone under the age of 18 years.  It took the FDA another year to issue a warning of increased suicide in youths under 18 years old.  No letters were sent to physicians.  And the drug companies created marketing campaigns specifically to get antidepressants into the offices of all types of physicians, not just psychiatrists.

More than 10 million prescriptions for antidepressants are issued each year for children younger than 18 in the U.S.  Any physician, not just psychiatrists, can write prescriptions for psychiatric drugs.  The age of children being given these powerful mind-altering drugs continues to get younger.  Ohio physicians in the month of July 2004 prescribed psychiatric drugs for 696 babies aged newborn to 3 years old covered by Medicaid.

“It’s shocking,” said Dr. Ellen Bassuk, associate professor of psychiatry at Harvard Medical School.  “These medications are not benign.  They can have dangerous side effects.  Who is being helped by children being drugged, the babies or the caregivers?”

Scientific Evidence of Antidepressants’ Effects on Newborns

“When we put pregnant women on antidepressants, they can’t get off them,” an unconcerned gynecologist told my friend C. when she told him she had spent years trying to get off the antidepressant he had prescribed to her.  Three years before this callous physician’s comments to C., the extreme health risks to the fetus had been reported in medical journals.

A study published in The New England Journal of Medicine in February 2006 reports pregnant women taking antidepressants have babies who are 6 times more likely to have primary pulmonary hypertension (PPH) or a developing lung disorder.  PPH is extremely serious. A baby’s organs such as brain, kidney and liver are stressed due to lack of oxygen.  PPH requires neonatal intensive care. PPH can be fatal and for babies who do survive there is often long-term health problems including breathing difficulties, seizures and developmental disorders.

Women taking SSRI/SNRI drugs during the first trimester of pregnancy are at 60 percent greater risk of their babies having heart defects and 40 percent greater risk of their babies suffering malformation.

“In conclusion, our results suggest that maternal exposure to fluoxetine (Prozac, Luvox, Sarafem and Symbyax) during pregnancy and lactation results in enduring behavioral alterations… throughout life,” a study reports in Pharmacology, spring 2007.  Although the study was done with mice the physiological systems are similar to humans.  There is nothing preventing drugs a pregnant woman takes from going directly into the bloodstream and then all the tissues of the fetus.  And as this study indicates, antidepressants are also transferred to the baby through the mother’s milk.

As of February 2009, the drug companies, using their puppets and financial influence, are lobbying the U.S. Senate to pass a bill called the Mothers Act.  This insane bill has already passed the U.S. House of Representatives.  Supposedly this bill is meant to address postpartum depression.  The truth is that it’s the drug industry influencing legislation in order to have more taxpayers’ money flow into drug companies’ profits.  The 1,200 drug industry lobbyists on Capitol Hill are greasing the skids well so that this dangerous legislation that will harm, not help mothers, babies, and American families will easily pass.  It’s about money, not health.

RETURN TO BLOGS PAGE


  • Share/Bookmark